On Wednesday shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) closed at $8.10. Company’s sales growth for last 5 years was 66.20% and EPS growth for next 5 years is recorded as 41.40%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on March 19, 2015, released that it is schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2015, taking place Saturday, April 18 through Wednesday, April 22, 2015, in Philadelphia.
ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity moved down -0.11% to close at $8.94. Company weekly performance is 9.69% while its quarterly performance stands at 48.50%. ImmunoGen, Inc. (NASDAQ:IMGN) is -42.66% away from its 52 week high. ImmunoGen, Inc. (NASDAQ:IMGN) reported a $200 million non-dilutive royalty transaction with funds managed by TPG Special Situations Partners (“TSSP”). In return for the payment to ImmunoGen, TSSP will have the right to receive 100% of the royalty revenue on Kadcyla® commercial sales that would otherwise be paid by Roche to ImmunoGen until TSSP has received a total of either $235 million or $260 million, depending on timing. After this threshold is met, if ever, ImmunoGen will receive 85% of the Kadcyla royalty revenue and TSSP will receive 15% of the Kadcyla royalty revenue until this revenue stream ends. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in early April 2015.
On last trading day UIL Holdings Corporation (NYSE:UIL) moved down -0.70% to close at $51.06. Its volatility for the week is 1.76% while volatility for the month is 1.79%. UIL’s sales growth for past 5 years was 12.70% and its EPS growth for past 5 years was 0.00%. UIL Holdings Corporation (NYSE:UIL) monthly performance is 2.18%. Ibedrola, Spain’s largest electricity utility, recently announced the purchase of UIL Holding Corporation (NYSE:UIL) to expand its presence in the United States.
Colfax Corporation (NYSE:CFX) has 8.60% insider ownership while its institutional ownership stands at 87.00%. In last trading activity company’s stock closed at $47.94. Robert W. Baird assumed coverage on shares of Colfax Corp (NYSE:CFX) in a research note issued to investors on Friday. The firm issued a market perform rating and a $53.00 price target on the stock.
On Wednesday shares of CME Group Inc. (NASDAQ:CME) closed at $94.50. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 13.83%. CME Group Inc. (NASDAQ:CME) won the first round of a battle of two new euro-based cocoa futures contracts against rival exchange ICE Futures. More than 200 lots traded through the CME contract on Monday, marking the exchange’s entry into deliverable soft commodities as it seeks to break ICE’s dominance of cocoa futures trading.